In addition, providing sufficient co-stimulatory signals may be a promising strategy to overcome deficient IFN-γ release from circulating MAIT cells as observed in systemic lupus erythematodes (90), inflammatory bowel disease (91), or liver cirrhosis (92). Here, IFNG is linked to inflammatory bowel disease.